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Abstract
The production of high levels of reactive oxygen species by neutrophils is associated with the local and systemic
destructive phenotype found in the chronic inflammatory disease periodontitis. In the present study, we investigated
the ability of sulforaphane (SFN) to restore cellular glutathione levels and reduce the hyperactivity of circulating
neutrophils associated with chronic periodontitis. Using differentiated HL60 cells as a neutrophil model, here we show
that generation of extracellular O2. - by the nicotinamide adenine dinucleotide (NADPH) oxidase complex is increased
by intracellular glutathione depletion. This may be attributed to the upregulation of thiol regulated acid
sphingomyelinase driven lipid raft formation. Intracellular glutathione was also lower in primary neutrophils from
periodontitis patients and, consistent with our previous findings, patients neutrophils were hyper-reactive to stimuli.
The activity of nuclear factor erythroid-2-related factor 2 (Nrf2), a master regulator of the antioxidant response, is
impaired in circulating neutrophils from chronic periodontitis patients. Although patients’ neutrophils exhibit a low
reduced glutathione (GSH)/oxidised glutathione (GSSG) ratio and a higher total Nrf2 level, the DNA-binding activity
of nuclear Nrf2 remained unchanged relative to healthy controls and had reduced expression of glutamate cysteine
ligase catalytic (GCLC), and modifier (GCLM) subunit mRNAs, compared to periodontally healthy subjects
neutrophils. Pre-treatment with SFN increased expression of GCLC and GCM, improved intracellular GSH/GSSG
ratios and reduced agonist-activated extracellular O2. - production in both dHL60 and primary neutrophils from
patients with periodontitis and controls. These findings suggest that a deficiency in Nrf2-dependent pathways may
underpin susceptibility to hyper-reactivity in circulating primary neutrophils during chronic periodontitis.
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Introduction
Periodontitis is a ubiquitous chronic inflammatory disease
initiated by a microbial biofilm, and in which a dysregulated
immune-inflammatory response leads to destruction of the
supporting tissues of the tooth and ultimately tooth loss. Apart
from the damage caused locally to the periodontium,
periodontitis is also recognised as a significant risk factor for
atherogenic vascular disease [1] and type II diabetes [2]. There
is evidence that oxidative stress is one of the key factors
explaining some of the systemic pathophysiological
mechanisms associated with inflammatory conditions such as
periodontitis [3].
Although the underlying mechanisms of chronic periodontitis
remain unclear, peripheral blood neutrophil hyper-activity (un-
stimulated cells) and -reactivity (to a stimulus) is a key feature
of the disease [4,5]. Reactive oxygen species (ROS)
production by neutrophils during the respiratory burst is
important in clearing local periodontal pathogens but is thought
to be a significant factor in the aetiology of local tissue damage
[3,6]. It has been previously shown that gingival crevicular fluid
which protects the periodontal tissues, has less buffering
capacity against ROS in periodontitis patients than in healthy
controls [7]; the reduced glutathione (GSH) concentration is
lower in the extracellular environment in periodontitis. It is likely
that this is a consequence of increased ROS production by
neutrophils in periodontitis patients.
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The generation of the superoxide anion radical via
nicotinamide adenine dinucleotide phosphate (NADPH)
oxidase is the first step in the production of a range of reactive
oxygen species. Although superoxide (O2.-) initiated cascades
of reactions are important in clearing foreign pathogens, largely
within the safe confines of the phagocytic vacuole, sustained
NADPH oxidase (NOX) activation is considered to result in
adverse effects on the host [3]. This is antagonised by cellular
systems which include naturally occurring enzymes e.g.
catalase, superoxide dismutase, glutathione (GSH) peroxidase,
thioredoxin reductase and smaller molecular peptides and
proteins e.g. intracellular glutathione and thioredoxin, which
prevent the uncontrolled formation of free radicals and other
reactive oxygen species. Among these, glutathione (GSH)
plays a pivotal role in cellular redox homeostasis [8].
Redox regulation of gene expression and activity is
described for many proteins [9] and enzymes that undergo
reversible thiol oxidation [10]. Acid sphingomyelinase
(ASMase) is indirectly activated in this way and its activation
correlates with its translocation from intracellular stores onto
the extracellular leaflet of the cell membrane [11]. SMase
hydrolyzes sphingomyelin to ceramide and phosphocholine
[11,12]. It has been shown that ceramide is incorporated to
stabilise lipid rafts (LR), which are regions of cell membranes
with a distinct lipid composition and which appear to act as
platforms, called “ceramide-enriched membrane platforms”
[13,14], to localize proteins involved in intracellular signalling.
The contribution of lipid rafts to the efficient activation of the
NADPH oxidase has been investigated in neutrophils in several
studies [15–18]. It was also hypothesised that lipid raft
platforms with aggregated NOX-4 subunits form a number of
lipid raft associated NOX-4 complexes, which results in
increased production of O2. - by endothelial cells [14].
The association between low antioxidant defence and
increased biomarkers of oxidative damage in periodontitis
plasma has been investigated in several studies [3]. Whilst
biomarker levels of oxidative damage such as 8-
hydroxydeoxyguanosine (8-OHdG), lipid peroxidation products
[19], and protein carbonyl [20] levels are found to be increased
in patients with periodontitis, serum enzymatic antioxidants
such as superoxide dismutase (SOD), catalase (CAT),
glutathione peroxide (GSHPx), and non-enzymatic antioxidants
(GSH, vitamins E and C) are found to be significantly lower [19]
than healthy control subjects. The extracellular redox
environment has been suggested to impact on intracellular
redox state and cellular metabolism [7,21]. We have previously
shown that even after non-surgical therapy, extracellular GSH
levels remain low in gingival crevicular fluid in chronic
periodontitis patients than disease free controls [7]. The
exogenous ROS burden creates an ‘oxidatively stressed’
environment mainly by generating intracellular H2O2, which acts
as a second messenger in cell signalling pathways. H2O2
reacts with freely accessible protein thiolate anions to form cys-
sulfenic acids or is further oxidised to disulfide bonds. Most of
these reactions are reversible in the presence of cellular thiol/
disulfide systems; GSH/GSSG, thioredoxin/ thioredoxin
reductase, and cysteine/cystine [22]. However, in the presence
of excessive oxidation, cysteine and GSH depletion can result,
which eventually overwhelms endogenous oxidation-reduction
(redox) reactions. Intracellular redox status is very important in
protein function and to maintain cellular homeostasis, however,
whether the intracellular redox state is altered in periodontitis is
unknown.
Nuclear factor (erythroid-derived 2)-related factor 2 (Nrf2) is
a helix–loop–helix basic leucine zipper transcription factor
retained in the cytoplasm that is subject to redox regulation.
Nrf2 is expressed by nearly all cell types, where its function is
suppressed and sequestered in the cytosol by the Kelch-like
Erythroid-cell-derived protein with CNC homology (ECH)-
Associated Protein 1 (Keap1). Two reduced cysteine residues
(cys273 and cys288) in Keap1 are required for ubiqutination of
Nrf2 [23,24]. Keap1-Nrf2 interaction prevents Nrf2 nuclear
translocation and so prevents activation of target genes
through binding to the antioxidant response element (ARE).
Upon challenge by oxidants Nrf2 does not undergo
ubiquitination and is released from Keap1 as a result of the
modification of cysteine residues in Keap1 and/or
phosphorylation of Nrf2. Activated Nrf2 translocates to the
nucleus, where it binds to promoters and upregulates Nrf2-ARE
target genes such as heme oxygenase-1 (HMOX1), glutamate
cysteine ligase catalytic (GCLC), and modifier (GCLM)
subunits, and NADPH-quinone oxidoreductase (NQO1).
Cellular and extracellular glutathione concentrations are
therefore under redox control via Nrf2; and the loss of
intracellular glutathione increases cellular peroxides, promotes
release of Nrf2 from Keap1 following thiol oxidation, triggers
increased de novo glutathione synthesis via the rate limiting
enzyme γGCS and restoration of the cellular redox state.
Further regulation of the Nrf2 pathway is achieved via removal
of oxidised Keap 1, which has recently been reported to
undergo autophagic turnover in liver cells [25].
Sulforaphane (SFN) is a natural product found in cruciferous
vegetables. Although the exact mechanism is not fully
understood, SFN is known to induce Nrf2 dependent
antioxidant gene expression by binding to cys151 on Keap-1
[24]. SFN also acts as an inhibitor of histone deacetylase
(HDAC); which is involved in altered histone acetylation status
and increased p21Cip1/Waf1 expression in human embryonic
kidney cells [26]. The protective effects of SFN against
oxidative damage have been studied in various in vitro [27] and
in vivo [28] models and recently, the role of Nrf2 activity in
modulating innate immune responses has been investigated in
sepsis [29].
To date, neutrophil redox state, Nrf2 expression and activity
have not been studied in subjects with periodontitis. Here we
test the hypothesis that chronic inflammatory periodontitis is
associated with impaired Nrf2 activation and function,
insufficient glutathione synthesis and depletion of the
glutathione pools, which in turn mediates a hyperactive and
hyper-reactive neutrophil phenotype. We have also
investigated a protective effect of SFN in reducing periodontitis
patient neutrophil hyperactivity ex vivo.
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Materials and Methods
Materials
Anti-Nrf2 polyclonal antibody was purchased from Invitrogen
(Paisley, UK). All other reagents were obtained from Sigma
Chemical Company (Poole, UK) unless otherwise stated.
Volunteers
Consenting volunteers were recruited from chronic
periodontitis patients (n=15; eight males and seven females;
age range 43-57 years) attending Birmingham Dental Hospital.
Chronic periodontitis was defined as previously described [30].
Age- and sex-matched periodontally healthy consenting control
subjects (n=15; eight males and seven females; age range
40-60) were recruited from staff of the Birmingham Dental
Hospital. All volunteers were systemically healthy, non-
smokers, not pregnant and did not use recreational drugs at
the time of sample collection. Ethical approval for the study
was granted by South Birmingham Local Research Ethics
Committee (South Birmingham LREC 05Q/2707/252; Am01/1)
and donors gave their informed written consent after the risks
and benefits of partaking in the study were explained.
Collection and isolation of peripheral blood neutrophils
Venous blood was collected into lithium heparin (17 IU/ml)
Vacutainer™ (Greiner Bio One Ltd.) tubes. Neutrophils were
isolated as described by Matthews et al [3] using Percoll®
density centrifugation (Invitrogen, Paisley, UK). Isolated cell
viability was determined immediately before analysis by trypan
blue exclusion and was typically >98%. Primary neutrophils
were cultured in RPMI1640 media containing 10% foetal
bovine serum and 200U/ml penicillin and streptomycin in the
presence or absence of 5µM SFN for 16 hours. Viability was
determined by trypan blue exclusion.
Cell culture
Human promyelocytic (HL60) cells from ATCC were
maintained in RPMI 1640 media containing 10% foetal bovine
serum and 200U/ml penicillin and streptomycin at 370C in a
humidified atmosphere of 5% CO2 and 95% air. HL60 cells
were differentiated into a neutrophil-like cell line (dHL60) by
maintaining cells in media containing 1% DMSO for 5 days.
Chemiluminescence assay for extracellular superoxide
anion radical production
To determine the respiratory burst activity of resting and
activated neutrophils, lucigenin-dependent chemiluminescence
was monitored over one hour as previously described [4].
Briefly, PBS-washed primary neutrophils (5 × 105 cells) in
100 µL of 1% BSA-PBS buffer were incubated with 100 µM
lucigenin in white microplate wells previously blocked with 1%
BSA overnight. After equilibration to 37°C for 30 min, light
emission in relative light units (RLUs) was recorded in order to
study baseline/resting superoxide anion radical release for
30 min. This was followed by the addition of fMLP (1 µM), 25µl
of opsonised S. aureus (300 bacteria/neutrophil), F. nucleatum
suspension (heat killed non-viable bacteria x100/neutrophil),
10nM phorbol 12-myristate 13-acetate (PMA) or PBS
(unstimulated control) to stimulate the respiratory burst, and
further measurements were recorded for another 30 min. All
samples were analysed in triplicate, with paired patient and
control samples analysed at the same time, and under the
same conditions. Mean maximum RLUs were plotted for each
experiment.
Measurement of intracellular GSH and GSSG levels
After 16 hours incubation, SFN-treated cells and non-treated
control neutrophils (5×105 cells) were pelleted, washed twice
with PBS and the pellet was air dried for 5min. Sulfosalicylic
acid (SSA; 3.33µl of 100% made up in distilled water) was then
added to the cell pellet, vortexed and immediately centrifuged
at 6600 ×g for 1.5 min. Stock buffer (96.6µl of 125mM sodium
phosphate, 6.3mM disodium EDTA, pH 7.5) was then added to
each tube, vortexed and re-centrifuged as above. Supernatants
were collected into fresh tubes and GSH and GSSG levels
were assessed by the GSR-DTNB recycling assay as
described in Gherghel D, et al. [31], on the same day or
samples were immediately stored at -800C for analysis within
one month. Protein concentration was measured by
bicinchoninic assay (BCA assay).
Measurement of acid sphingomyelinase (ASMase)
activity
ASMase activity in dHL60 cells was measured as described
previously with some modifications [32]. dHL60 cells (1×107)
were centrifuged and washed with ice-cold PBS to remove
media. The cell pellet was resuspended in 1ml of a lysis buffer
(25mM Tris–HCl buffer (pH 5), 2mM EDTA, 2mM EGTA, 1mM
phenylmethylsulfonyl fluoride, 20µg/ml E-64). Cell extracts
were homogenised by passing through a 25G needle 5 times
and used as the enzyme source.
The assay mixture contained the following components in a
total volume of 200µl: 15mM HADPC (2-N-
hexadecanoylamino-4-nitrophenylphosphoryl choline;
Calbiochem, UK), 100mM Tris–HCl buffer (pH 5), 10mM MgCl2,
and 10µl of the enzyme source. Incubation followed at 370C for
60 min; the enzyme reaction was terminated by adding 400µl
100mM glycine buffer (pH 10.5) and 700µl ethanol. The
suspension was vortexed and centrifuged at 2000 × g for 10
min. The absorbance of the supernatant solution was
measured spectrophotometrically at 410 nm.
Isolation of lipid raft microdomains by gradient
centrifugation
dHL60 cells (1×107 cells) were lysed in 1 ml MNE buffer
(150mM NaCl, 2mM EDTA, 25mM MES, with 1% protease
inhibitor cocktail, pH6.5) containing 1% Triton X-100 on ice for
30min. Cell extracts were homogenized by 5 passages through
a 21-gauge needle. Lysates were obtained by centrifuging at
14,000g, 4°C for 5 min to remove the nuclei and insoluble
materials. The cell lysates (1ml) were mixed 1:1 with 85%
sucrose solution, layered in the bottom of the centrifuge tube
(Ultra clear™ Beckman centrifuge tubes) and overlaid
sequentially with 6ml 30% and 3.5ml 5% sucrose solution to
make a non-continuous sucrose gradient. Samples were
Dysregulation of Nrf2 in Periodontitis
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centrifuged at 20 000g for 16 hours at 4°C using a SW41Ti
rotor (Beckman). Nine 1ml fractions were collected from the top
and proteins in each fraction were precipitated with 5%
trichloroacetic acid for 30 minutes on ice. Proteins in lipid raft
(LR) fractions were isolated by centrifugation at 13 000 x g,
4°C, for 15 minutes. The protein pellet was carefully washed
with cold acetone twice, air dried, and then resuspended in
modified Laemmli buffer (4M urea, 0.2% ABF-14, 20% DMSO,
4% SDS, 20% glycerol, 10% 2-mercaptoethanol, 0.004%
bromophenol blue and 0.125M Tris-HCl, pH 6.8). Samples
were heated 5 min at 950C before storage at -200C for later
analysis by western blot.
Western blot analysis of proteins in lipid rafts
For immunodetection of LR-associated proteins, 15µl of each
fraction in modified Laemmli buffer were subjected to 10%
SDS-PAGE, transferred onto a PVDF membrane, and blocked
with 3% BSA. The membrane was probed with primary
monoclonal antibodies anti-flotillin-1 (1:1000, BD Biosciences),
for 2 hours at room temperature followed by extensive washing
then incubation with horseradish peroxidase–labeled anti-rabbit
IgG (1:5000) for 2 hours. The immunoreactive bands were
detected by enhanced chemiluminescence methods (GE
HealthCare).
Preparation of nuclear and cytosolic extracts and Nrf2
activity assay
Nuclear and cytosolic extractions (3×105 cells) were
prepared using the Active Motif Nuclear extraction kit (Active
Motif, Carlsbad, Calif) according to the manufacturer’s
instructions. Samples were immediately stored at -800C.
Protein concentrations were measured spectrophotometrically
(NanoDrop). Nrf2 nuclear binding was assessed by using an
ELISA based Nrf2 TransAM transactivation kit (Active Motif,
Carlsbad, Calif) according to manufacturer’s instructions.
Briefly, five µg of nuclear protein was incubated in 96-well
plates pre-coated with ARE consensus oligonucleotides, and
the active-Nrf2 that bound to the oligonucleotide was detected
HRP-conjugated secondary antibody. The absorbance was
read using a plate reader at 450nm, and absorbance was
expressed as the direct activity of Nrf2.
RNA extraction and quantitative polymerase chain
reaction (qPCR)
Nrf2-regulated antioxidative gene expression was measured
in neutrophils by quantitative PCR. Total RNA was extracted
from the cells (1x106) using TriZol reagent (Invitrogen,
Carlsbad, CA) according to the manufacturer’s instructions.
RNA was treated with DNase (Qiagen) for 30 minutes at room
temperature. RNA was subsequently purified using the
RNAeasy Kit (Qiagen). RNA quantification was performed
using the Nanodrop 1000 (Thermofisher). 1 µg of total RNA
was reverse transcribed using Precision nanoscriptTM reverse
transcriptase (Primerdesign, Southampton UK) and oligo dT
primers (PrimerDesign, Southampton, UK). cDNAs were
amplified in a standard 40-cycle SYBR® green real-time PCR
reaction using optimised sequence specific pre-validated
primers supplied by PrimerDesign Ltd (Southampton UK),
according to the manufacturer’s instructions. cDNA was used
for quantitative PCR analyses of selected genes heme
oxygenase-1 (HMOX1), glutamate cysteine ligase catalytic
(GCLC), and modifier subunits (GCLM), and NADPH-quinone
oxidoreductase (NQO1) using primers commercially available
from PrimerDesign Ltd (Southampton UK). β-Actin was used
for normalization. Fold changes in gene expression using the
comparative CT method and statistical analysis were
determined using the freely available Relative Expression
Software Tool (REST 2009, www.qiagen.com).
Preparation of whole cell extracts for Nrf2 and Keap 1
western blot
Neutrophils were pelleted, washed twice with ice-cold PBS
and resuspended in 100µl of ice-cold lysis buffer [50 mM Tris-
HCl (pH 6.8), 10% (vol/vol) glycerol, and 2% (wt/vol) SDS].
After 10 min on ice, cells were sheared by passing five times
through a G21 needle and syringe to reduce DNA viscosity.
Samples were centrifuged for collection of the supernatants
containing total proteins. Protein concentration was measured
using BCA assay. Laemmli sample buffer (100µl) was added,
vortexed and stored at -200C. Western blot analysis for Nrf2
was performed as described previously [33] using 20µg of
isolated soluble proteins. To detect Keap-1, membranes were
blocked with 3% BSA in PBS-T (0.05% Tween 20 in PBS) for
2hrs, treated with primary antibodies overnight followed by
HRP-conjugated secondary antibody for 2hrs. Protein signals
were developed with ECL Plus reagents (Amersham). For
quantification, densitometric integration of the bands of interest
was undertaken using a GS800 scanner with Quantity One
(version 1.34r; Biorad).
Data analysis
Data were analysed using Graphpad Prism software (version
5). Unless specified all data are presented as the mean±SEM
of at least three independent experiments, performed in
triplicate. Statistical analysis was performed using analysis of
variance followed by Tukey’s multiple comparison test.
Results
Sulforaphane increases intracellular GSH/GSSG ratio
and decreases the PMA stimulated respiratory burst in
dHL60 cells
To study the change in intracellular redox environment on
dHL60 cell response to stimulus and the effect of SFN,
intracellular GSH (Figure 1A) and GSSG (Figure 1B) levels
were measured pre- and post-SFN treatment. The glutathione
synthesis inhibitor; BSO (10µM for 16 hours) significantly
decreased intracellular GSH concentration in dHL60 cells
(12.8±2 nmol/mg protein; P<0.01) compared to untreated
control cells (25.8±0.9 nmol/mg protein). SFN (5µM for 16
hours) increased intracellular GSH levels to 29.4±0.5 nmol/mg
protein. The change in intracellular GSSG levels was not
significant between treatments. As a result, the dHL60 cell
GSH/GSSG ratio (Figure 1C) was significantly decreased with
BSO treatment and GSH/GSSG appeared higher following
Dysregulation of Nrf2 in Periodontitis
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SFN treatment. Cell viability was not affected by any treatment
(Figure S1 in File S1).
In order to investigate the dHL60 cell respiratory burst under
GSH depletion with BSO, cells were stimulated with 10nM PMA
(Figure 1D). PMA enhanced the lucigenin-sensitive respiratory
burst in BSO pre-treated dHL60 cells (51.3± 2.1RLU; P<0.05)
compared to controls (34.6 ± 2.1RLU). A significant decrease
in the respiratory burst (18.9± 0.4RLU; P<0.05) response to
PMA was observed with SFN treated dHL60 cells. SFN
treatment did not change phagocytic ability of dHL60 cells as
measured by flow cytometry suggesting that the effect of SFN
on the respiratory burst is not attributed to a generally
decreased functional activity (Figure S2 in File S1).
dHL60 cell ASMase activity and lipid raft rearrangement
is increased by GSH: GSSG depletion
The change of intracellular redox environment following BSO
treatment may affect the activity of redox sensitive proteins
such as ASMase (Figure 2A). dHL60 cells treated with 10µM
BSO for 16 hours increased ASMase activity by 2.5 fold
compared to the control cells (P < 0.001). Desipramine, an
inhibitor for ASMase significantly decreased ASMase activity
with in both BSO untreated control (10 fold) and BSO treated
cells (5 fold; P < 0.05). SFN, an inducer for Nrf2 nuclear
translocation significantly decreased ASMase activity by 2 fold
compared to untreated control cells (P<0.05). Lipid rafts (LR)
are re-arranged in redox stressed and stimulated dHL60 cells
(Figure 2B). Compared to untreated dHL60 cells, fMLP and
PMA stimulated cells are rich in the LR marker protein flotillin-1
in fractions 3-4. BSO treated dHL60 cells show further up-
regulation of flotillin-1 into LR fractions. The cholesterol-
Figure 1.  Effects of BSO and SFN pre-incubation on dHL60 cell GSH/GSSG ratio and respiratory burst.  dHL60 cells were
treated with 10µM BSO or 5µM SFN for 16 hours. GSH (A) and GSSG (B) concentrations were measured by the DTNB recycling
assay in order to determine the GSH/GSSG ratio (C). Mean peak lucigenin chemiluminescence generated by dHL60 cells was
plotted (RLU ± standard error of the mean) (D). Data represent three independent experiments of three replicates. Significant
differences were calculated with one way ANOVA followed by Tukey’s multiple comparison test, where *P<0.05.
doi: 10.1371/journal.pone.0066407.g001
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depleting agent 10mM methyl-β-cyclodextrin (MβC) for 1 hour
induced redistribution of lipid raft marker protein, flotillin into
non-raft fractions.
SFN increases intracellular glutathione in primary
neutrophils
To determine whether in vitro cell culture studies were
reproducible in periodontitis patients, who have previously
been reported to have lower extracellular GSH concentrations
[5], blood samples were obtained and primary neutrophils were
isolated from 12 periodontitis patients and age/gender matched
healthy volunteers. The redox state of neutrophils was
determined by analysing the intracellular GSH/GSSG ratio
(Figure 3). Patient neutrophils were significantly higher in
GSSG concentration (2.04±0.1nmol/mg protein) compared to
controls (1.16± 0.07nmol/mg protein). Pre-incubation with SFN
for 16 hours significantly increased intracellular GSH
concentrations in both control (14.83±0.6 nmol/mg protein) and
patient (19.62±0.5 nmol/mg protein) groups. The levels of
GSSG in SFN-treated control (1.2±0.11 nmol/mg protein) and
Figure 2.  Effects of oxidative stress on ASMase activity and LR rearrangement.  (A) BSO (10µM) pre-treated and untreated
dHL60 cells were treated with or without desipramine (10 µM, 1 hour) and 5µM SFN. Cells (1×107) were collected on ice-cold PBS,
pelleted and lysed before analysing ASMase activity. (B) LRs from dHL60 cells were extracted with MNE buffer containing 1% triton
X-100 and applied to discontinuous sucrose gradients, as described in Methods. Proteins were extracted and immunoblotted using
anti-flotillin-1 as the raft protein detecting antibody. (C) Quantification of flotillin in lipid raft fractions 3 and 4 compared to total
expression.
doi: 10.1371/journal.pone.0066407.g002
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patient (1.76±0.04 nmol/mg protein) cells were unaffected. The
intracellular GSH/GSSG ratio was significantly increased after
16 hours of SFN treatment in both patients (P<0.01) and
control subjects (P<0.05).
SFN reduces neutrophil respiratory burst
In order to investigate the effect of SFN on the neutrophil
respiratory burst, primary neutrophils were pre-treated with
SFN or vehicle for 16 hours. Neutrophils were stimulated with
fMLP, opsonised S. aureus, heat-killed F. nucleatum (60°C) or
PMA (Figure 4 A–D respectively) and lucigenin-dependent
chemiluminescence was measured. Periodontitis patients’
neutrophils showed significantly greater hyper-reactivity
towards all four stimulations compared to neutrophils from
healthy subjects (p<0.05). SFN treatments did not significantly
change neutrophil cell viability measured at 16 hours by trypan
blue (Figure S3 in File S1). Both control and patient neutrophils
showed decreased lucigenin-dependent chemiluminescence in
response to all stimuli after SFN treatment. While extracellular
superoxide production measured by lucigenin-dependent
chemiluminescence is inhibitable by the addition of superoxide
dismutase at the peak of the respiratory burst, addition of
extracellular N-acetyl-cysteine (NAC) or SFN on maximally
activated neutrophils did not quench the signal (Figure S4 in
File S1).
SFN increases primary neutrophil Nrf2 levels
Low doses of SFN exert indirect antioxidant properties via
Nrf-2 mediated gene expression. To investigate whether SFN
prevents the neutrophil respiratory burst by up-regulation of
Nrf2, cell lysates were examined for Nrf2 expression by
immunoblotting. Total Nrf2 expression was examined by
Figure 3.  SFN pre-incubation increases the GSH/GSSG ratio in primary neutrophils.  GSH (A) and GGSG (B) concentrations,
along with the GSH/GSSG ratio (C) were measured using the DTNB recycling assay and expressed relative to protein content.
Significant differences were calculated with Tukey’s multiple-comparison test where*P<0.05, and ***P<0.001.
doi: 10.1371/journal.pone.0066407.g003
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western blotting after treatment with different doses (0, 1, 2, 5,
10 or 15µM) of SFN for 2, 4, 8, 16 and 24hrs. Exposure of
neutrophils to increasing concentrations of SFN led to an
increase in total Nrf2 level (Figure S5A in File S1). Incubation
with 5, 10 and 15µM SFN resulted in an increase in Nrf2
protein level by 68%, 70% and 77% over control cells,
respectively. In time course experiments a significant nuclear
translocation of Nrf2 was observed after 4hrs treatment with
5µM SFN and this was further increased at 8 and 16 hrs
(Figure S5B in File S1). Nuclear translocation of Nrf2 at 24hrs
was not significantly different to 16hrs. Keap-1 protein level
was reduced at 4 hrs but restored at 16 hrs (Figure S5B in File
S1). Figure 5A shows that SFN increases Nrf2 protein levels in
neutrophil cell lysates from control subjects. In the absence of
SFN, patient neutrophils show increased Nrf2 expression
compared to healthy control cells. Keap-1 protein levels were
not different between control and patient neutrophils in the
absence of SFN but were depleted in control subjects only after
SFN treatment for 16hrs (Figure 5B). Nrf2-ARE binding efficacy
(Figure 5C) was not significantly different between control
(0.38±0.03 arbitrary units; AU) and patients (0.41±0.03AU).
SFN treatments increased DNA binding activity in both control
(0.49±0.01AU) and patients (0.47±0.04AU) nuclear fractions.
The transcription factor Nrf2 regulates the gene expression of a
number of phase II genes such as HMOX1, GCLC, and GCLM,
and NQO1, which increases cellular glutathione (GSH)
synthesis. Figure 5D shows that GCLC and GCLM relative
mRNA expression levels were significantly down regulated in
the patient group by a mean factor of 0.305 and 0.215
respectively (P<0.05). SFN treatments for 16 hours significantly
increased relative mRNA expression in both groups for GCLC,
GCLM and NQO1 (Figure 5E) but not HMOX1 where the lack
of response was in patient neutrophils but not in normal
subjects.
Figure 4.  SFN pre-incubation decreases neutrophil respiratory burst.  Peak relative light unit (RLU) values for neutrophils
stimulated with (A) 1µM fMLP, (B) opsonised S. aureus (300 bacteria/neutrophil) (C) F. nucleatum bacteria x100/neutrophil and (D)
10nM PMA in the presence or absence of SFN treatment were plotted and significant differences were calculated using Tukey’s
multiple-comparison test, where, * p<0.05 and **p<0.01.
doi: 10.1371/journal.pone.0066407.g004
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Figure 5.  Effect of SFN on Nrf2 protein expression and activity in primary neutrophils.  (A) Western blotting (left) and
quantification (right) of total Nrf2 expression in the presence or absence of SFN treatment. (B) Western blotting (left) and
quantification (right) of expression of Keap-1, Values are shown normalised to β-actin. (C) Analysis of Nrf2-DNA binding activity by
trans-AM nuclear activity assay. A representative experiment of the three is shown. *** P< 0.01. (D) qPCR analysis of GCLC and
GCLM gene expression levels of neutrophil mRNA from patients compared to control. (E) qPCR analysis of GCLC, HMOX1, GCLM
and NQO1 gene expression levels in neutrophils treated with 5 µM SFN for 16 hours, values normalised to actin.
doi: 10.1371/journal.pone.0066407.g005
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Discussion
The present study provides evidence to show that peripheral
blood neutrophils from patients with chronic periodontitis have
more oxidised (GSSG) relative to reduced glutathione (GSH)
compared to neutrophils from healthy control subjects.
Normally, the Keap1-Nrf2-ARE signalling pathway elicits an
adaptive response for cell survival under oxidative stress but
this did not appear to operate effectively in periodontitis
patients. To our knowledge this is the first study to reveal
disruption of the Nrf2 pathway as a mechanism underlying
redox disturbances and neutrophil hyperactivity/hyper-reactivity
in periodontitis. The results also demonstrate that SFN can
restore the intracellular redox state measured by GSH/GSSG
in neutrophils from controls and periodontitis patients ex vivo,
although this may be independent of Nrf2 activity. SFN
increased the expression of GCLC and GCLM mRNA and
GSH/GSSG ratio in both healthy primary neutrophils and
periodontitis patients mimicking the effect of SFN on GSH/
GSSG seen in differentiated HL60 cells. Subsequently, both
the primary neutrophil and dHL60-stimulated respiratory burst
was significantly decreased with SFN treatments. The potential
mechanism by which SFN exerts such protection is
represented in schematic Figure 6.
Healthy cells generally maintain a reducing intracellular
environment, relative to extracellular fluid compartments. A
major factor influencing the redox status of the cytosol is the
concentration of reduced glutathione [34]. It has been
estimated that cultured cells maintain a cytosolic GSH/GSSG
redox potential of -260mV to -200mV compared with the more
oxidised redox potential found in plasma, -140mV [35].
Pathophysiological conditions such as inflammation and ageing
[36] drive the cytosolic GSH/GSSG-coupled redox potential to
be more positive (oxidising). Experimentally, BSO has been
widely used to induce GSH depletion (hence increase redox
potential +30mV at 100µM BSO for 24hrs in HeLa cells [37])
Figure 6.  A possible mechanism for the up-regulation of NADPH oxidase activity under redox stress.  The pathway leading
to the formation of GSH by the action of γ-glutamylcysteine synthetase (γGCS) is blocked by buthionine sulfoximine (BSO), inducing
artificial stress condition in dHL60 cells. Decreased cellular GSH/GSSG ratio may activate redox sensitive enzymes such as
ASMases and nuclear translocation of Nrf2. ASMases may favour lipid raft formation and thereby clustering active NADPH oxidase
complexes in the outer membrane, subsequently liberating extracellular O2.-.
doi: 10.1371/journal.pone.0066407.g006
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due to its inhibitory effects on γGCS production, the rate
limiting enzyme in GSH synthesis [38]. The use of
differentiated HL60 cells as a valid model system to resemble
the functional properties of primary neutrophils has been
reported in several studies [39,40]. Differentiated HL60 cells
exposed to BSO for 16 hours showed a significantly depleted
cellular glutathione pool. However, the GSSG level was
generally maintained in dHL60 cells after treating with BSO for
16 hours. This created a decrease in cellular GSH/GSSG ratio
indicative of a more oxidised cellular environment. Compared
with healthy controls, patients with periodontitis had higher
GSSG concentrations whereas GSH levels were not
significantly different. As a result, patient neutrophils exhibited
a GSH/GSSG redox ratio consistent with a more oxidised state.
Cells generally maintain a reduced intracellular environment by
recycling GSH using the enzyme glutathione reductase, and by
exporting excess GSSG out of the cell. When these cycles are
overwhelmed, other cellular proteins may be irreversibly
oxidised. It has been shown that antioxidant treatments will
enhance the neutrophil redox state and the GSH/GSSG ratio
[41].
Nrf-2 is a transcription factor which regulates the basal and
inducible expression of a wide array of antioxidant genes.
Although the redox disturbances seen in periodontitis
neutrophils were accompanied by an expected upregulation of
Nrf2 expression, this did not translate to an increase in Nrf2-
ARE binding which instead was at the same level as control
subject neutrophils. Furthermore, Nrf2 targeted gene
expression was significantly down regulated for GCLC and
GCLM between control and patients neutrophils in the absence
of any ex vivo activating stimulus. However, with SFN
treatment ex vivo, neutrophil HMOX1, GCLC and GCLM
expression between control and patients was increased several
fold compared to non-treated control cells but NQO1 was only
increased in control subject neutrophils. Differential regulation
of HMOX1 and NQO1 is reported in ethanol induced murine
models of inflammation illustrating the complexity of
interactions between different transcription factors and such
complexity of transcription factor interactions may also
underpin the apparent failure to adapt to increasing GSSG in
patient neutrophils despite elevated Nrf2 levels [42]. Recent
studies have described the importance of Keap1 turnover after
oxidation via autophagic degradation paralleled by upregulation
of de novo transcription via redox sensitive transcription factors
AP2 and Sp1 [25]. Of note, turnover in Keap1 was evident in
control subjects but not patients and this may indicate greater
Keap 1 activity in periodontitis neutrophils which in turn may
afford greater inhibition on Nrf2. Together, this suggests that
the Nrf2 pathway in neutrophils is disrupted and cannot
facilitate adaptation to oxidative stress in chronic periodontitis.
Therefore the high expression of Nrf2 in unstimulated primary
neutrophils in patients does not appear to recover the cellular
redox balance in response to GSSG elevation. Alterations of
the Nrf2 pathway have been previously described in other
diseases such as chronic pulmonary disease [43], diabetic
nephropathy [44] and neurodegenerative diseases [45].
This study has not investigated the specific mechanism
underlying Nrf2 dysfunction in periodontitis. It is possible that in
addition to potential over activation of Keap 1 or lack of Keap1
turnover, Nrf2 in neutrophils is post-translationally modified in
periodontitis patients, which might interfere with its ability to
undergo nuclear trafficking. Post translational modifications of
Nrf2 including acetylation [46], phosphorylation [47] and
alterations in Keap1-dependent ubiquitination [33] are reported
in several studies. With the addition of SFN, the redox balance
of patient neutrophils was restored independently of Nfr2-ARE
binding, and associated with decreased hyperactivity/hyper-
reactivity. SFN is able to react with the thiol groups of Keap 1
and form thionacyl adducts promoting Nrf2 dissociation from
Keap1 and subsequent activation of ARE driven gene
expression and this may explain the increased GSH levels
measured in control cells following SFN treatment. However,
they do not explain the restoration of GSH in periodontitis
neutrophils, implicating an Nrf2 independent pathway for SFN
protection.
We have previously demonstrated lower GSH concentrations
in periodontitis patients relative to healthy controls within the
gingival crevicular fluid that bathes the periodontal tissues [48].
Moreover, mechanical anti-infective therapy, whilst successful
at reducing clinical inflammation, failed to restore GSH
concentrations to control patient levels, implying a
dysfunctional GSH synthesis pathway in periodontitis [7]. The
failure to adapt to sustained oxidative stress via Nrf2
antioxidant mechanisms may create an intracellular redox shift.
Redox sensitive proteins such as ASMase could become
activated in such environments. Evidence suggests that a more
oxidised intracellular redox state can activate ASMases [49].
Ceramide-rich membranes form stable cellular platforms,
where more NADPH oxidase complexes cluster together, as
reviewed in Li et al. [14],. Previous studies have shown that
NADPH oxidase subunit redistribution into lipid rafts could be
initiated by different stimuli [15,50,51]. Upregulation of the
respiratory burst in response to a PMA stimulus in GSH-
depleted dHL60 cells suggests that this environment favours
NADPH oxidase activity. Therefore, the more oxidising
intracellular redox state may affect NADPH oxidase membrane
assembly by altering lipid raft structure and promote
hyperactivity.
In summary, we have demonstrated for the first time that
significant redox disturbances exist in neutrophils of patients
with periodontitis and are associated with dysregulation of the
anti-inflammatory transcription factor Nrf2. Activation of the
redox sensitive protein ASMase, to promote lipid raft formation
and thereby assembly of the NADPH oxidase enzyme was also
mediated by a disruption in redox balance. These findings
highlight a potential mechanism for persistent hyperactivity in
neutrophils of periodontal patients. The use of SFN to
overcome Nrf2 dysregulation has given a promising insight to
restore neutrophil redox balance and reduce hyper-reactivity,
although the mechanism of this effect requires further
investigation.
Supporting Information
File S1.  Supplementary figures.  Figure S1: dHL60 cell
viability is not changed with 10µM buthionine sulfoximine
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(BSO) or 5µM sulphoraphane (SFN) treatments over 16 hours
as measured by trypan blue exclusion. Figure S2: dHL60 cell
phagocytic capacity is not compromised in the presence of
10µM buthionine sulfoximine (BSO) or 5µM sulphoraphane
(SFN) treatments measured by flow cytometry. dHL60 (2×105)
cells were incubated with 10µl of pHrodo™ E. coli
BioParticles® conjugate (Invitrogen, Paisley, UK) at 370C for
15min. The cells were centrifuged at 350g for 5 min and
discarded the supernatant. Cells were washed with PBS two
times before analysing by flow cytometer (Beckman coulter,
Inc, UK) equipped with a 488 nm argon-ion laser using a 585
nm emission filter. Figure S3: Primary neutrophil viability is not
affected by 5µM sulphoraphane (SFN) treatments for 16 hours
measured by trypan blue exclusion. Figure S4: Respiratory
burst measured by lucigenin dependent chemiluminescence is
not quenched by addition of 5mM N-acetyl cysteine (NAC) or
5µM sulphoraphane (SFN) when added at the peak of
neutrophil respiratory burst. Figure S5: Sulforaphane (SFN)
induced Nrf2 protein expression in primary control neutrophils.
Protein expression was detected by western blot. (A) To test
the dose–response to SFN, the cells were exposed to the
indicated concentrations of SFN for 16hrs. (B) To investigate
the time course of Nrf2 and Keap-1 expression; the cells were
exposed to 5µM sulforaphane for 1–24 hrs. The upper part
shows an original western blot for Nrf2 and Keap-1 (B)
expression; the lower part shows results of densitometric
analyses normalised to β-actin.
(PDF)
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